img

Global Peptide Health Products Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Peptide Health Products Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Peptide Health Products Market
Global Peptide Health Products market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Peptide Health Products industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
With the improvement of the quality of life, people pay more and more attention to health care. As a supplementary health care product, health care products have attracted more and more attention. Among the types of health products, health products containing peptides are highly sought after. Peptide-containing health products include collagen, protein powder, ganoderma peptide, etc.
Generally speaking, there are many types of health products, but the health products containing peptides are very effective. Peptides can enhance the body's immunity, promote the metabolism of skin cells, strengthen muscles, etc., and play a very important role in maintaining health.
Report Covers
This report presents an overview of global Peptide Health Products market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Peptide Health Products market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Amway
Suntory
GNC
Infinitus
Herbalife Nutrition
USANA Health Sciences, Inc.
Perfect (China) Co., Ltd.
Nestlé SA
H&H Group
China New Era Group Corporation
By-health
Black Mores
Glanbia Plc
Nature’s
Real Nutriceutical
China Beijing Tong Ren Tang Group
Xiamen Kingdomway
Segment by Type
Collagen
Protein Powder
Ganoderma Peptide
Others

Segment by Application


Tablet
Capsule
Oral Liquid
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Peptide Health Products introduction, etc. Peptide Health Products Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Peptide Health Products
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide Health Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Collagen
1.2.3 Protein Powder
1.2.4 Ganoderma Peptide
1.2.5 Others
1.3 Market by Application
1.3.1 Global Peptide Health Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Tablet
1.3.3 Capsule
1.3.4 Oral Liquid
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide Health Products Market Perspective (2018-2033)
2.2 Global Peptide Health Products Growth Trends by Region
2.2.1 Peptide Health Products Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Peptide Health Products Historic Market Size by Region (2018-2023)
2.2.3 Peptide Health Products Forecasted Market Size by Region (2024-2033)
2.3 Peptide Health Products Market Dynamics
2.3.1 Peptide Health Products Industry Trends
2.3.2 Peptide Health Products Market Drivers
2.3.3 Peptide Health Products Market Challenges
2.3.4 Peptide Health Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Peptide Health Products by Players
3.1.1 Global Peptide Health Products Revenue by Players (2018-2023)
3.1.2 Global Peptide Health Products Revenue Market Share by Players (2018-2023)
3.2 Global Peptide Health Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Peptide Health Products, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Peptide Health Products Market Concentration Ratio
3.4.1 Global Peptide Health Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide Health Products Revenue in 2022
3.5 Global Key Players of Peptide Health Products Head office and Area Served
3.6 Global Key Players of Peptide Health Products, Product and Application
3.7 Global Key Players of Peptide Health Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide Health Products Breakdown Data by Type
4.1 Global Peptide Health Products Historic Market Size by Type (2018-2023)
4.2 Global Peptide Health Products Forecasted Market Size by Type (2024-2033)
5 Peptide Health Products Breakdown Data by Application
5.1 Global Peptide Health Products Historic Market Size by Application (2018-2023)
5.2 Global Peptide Health Products Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Peptide Health Products Market Size (2018-2033)
6.2 North America Peptide Health Products Market Size by Type
6.2.1 North America Peptide Health Products Market Size by Type (2018-2023)
6.2.2 North America Peptide Health Products Market Size by Type (2024-2033)
6.2.3 North America Peptide Health Products Market Share by Type (2018-2033)
6.3 North America Peptide Health Products Market Size by Application
6.3.1 North America Peptide Health Products Market Size by Application (2018-2023)
6.3.2 North America Peptide Health Products Market Size by Application (2024-2033)
6.3.3 North America Peptide Health Products Market Share by Application (2018-2033)
6.4 North America Peptide Health Products Market Size by Country
6.4.1 North America Peptide Health Products Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Peptide Health Products Market Size by Country (2018-2023)
6.4.3 North America Peptide Health Products Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Peptide Health Products Market Size (2018-2033)
7.2 Europe Peptide Health Products Market Size by Type
7.2.1 Europe Peptide Health Products Market Size by Type (2018-2023)
7.2.2 Europe Peptide Health Products Market Size by Type (2024-2033)
7.2.3 Europe Peptide Health Products Market Share by Type (2018-2033)
7.3 Europe Peptide Health Products Market Size by Application
7.3.1 Europe Peptide Health Products Market Size by Application (2018-2023)
7.3.2 Europe Peptide Health Products Market Size by Application (2024-2033)
7.3.3 Europe Peptide Health Products Market Share by Application (2018-2033)
7.4 Europe Peptide Health Products Market Size by Country
7.4.1 Europe Peptide Health Products Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Peptide Health Products Market Size by Country (2018-2023)
7.4.3 Europe Peptide Health Products Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Peptide Health Products Market Size (2018-2033)
8.2 China Peptide Health Products Market Size by Type
8.2.1 China Peptide Health Products Market Size by Type (2018-2023)
8.2.2 China Peptide Health Products Market Size by Type (2024-2033)
8.2.3 China Peptide Health Products Market Share by Type (2018-2033)
8.3 China Peptide Health Products Market Size by Application
8.3.1 China Peptide Health Products Market Size by Application (2018-2023)
8.3.2 China Peptide Health Products Market Size by Application (2024-2033)
8.3.3 China Peptide Health Products Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Peptide Health Products Market Size (2018-2033)
9.2 Asia Peptide Health Products Market Size by Type
9.2.1 Asia Peptide Health Products Market Size by Type (2018-2023)
9.2.2 Asia Peptide Health Products Market Size by Type (2024-2033)
9.2.3 Asia Peptide Health Products Market Share by Type (2018-2033)
9.3 Asia Peptide Health Products Market Size by Application
9.3.1 Asia Peptide Health Products Market Size by Application (2018-2023)
9.3.2 Asia Peptide Health Products Market Size by Application (2024-2033)
9.3.3 Asia Peptide Health Products Market Share by Application (2018-2033)
9.4 Asia Peptide Health Products Market Size by Region
9.4.1 Asia Peptide Health Products Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Peptide Health Products Market Size by Region (2018-2023)
9.4.3 Asia Peptide Health Products Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Peptide Health Products Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Peptide Health Products Market Size by Type
10.2.1 Middle East, Africa, and Latin America Peptide Health Products Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Peptide Health Products Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Peptide Health Products Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Peptide Health Products Market Size by Application
10.3.1 Middle East, Africa, and Latin America Peptide Health Products Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Peptide Health Products Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Peptide Health Products Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Peptide Health Products Market Size by Country
10.4.1 Middle East, Africa, and Latin America Peptide Health Products Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Peptide Health Products Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Peptide Health Products Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amway
11.1.1 Amway Company Details
11.1.2 Amway Business Overview
11.1.3 Amway Peptide Health Products Introduction
11.1.4 Amway Revenue in Peptide Health Products Business (2018-2023)
11.1.5 Amway Recent Developments
11.2 Suntory
11.2.1 Suntory Company Details
11.2.2 Suntory Business Overview
11.2.3 Suntory Peptide Health Products Introduction
11.2.4 Suntory Revenue in Peptide Health Products Business (2018-2023)
11.2.5 Suntory Recent Developments
11.3 GNC
11.3.1 GNC Company Details
11.3.2 GNC Business Overview
11.3.3 GNC Peptide Health Products Introduction
11.3.4 GNC Revenue in Peptide Health Products Business (2018-2023)
11.3.5 GNC Recent Developments
11.4 Infinitus
11.4.1 Infinitus Company Details
11.4.2 Infinitus Business Overview
11.4.3 Infinitus Peptide Health Products Introduction
11.4.4 Infinitus Revenue in Peptide Health Products Business (2018-2023)
11.4.5 Infinitus Recent Developments
11.5 Herbalife Nutrition
11.5.1 Herbalife Nutrition Company Details
11.5.2 Herbalife Nutrition Business Overview
11.5.3 Herbalife Nutrition Peptide Health Products Introduction
11.5.4 Herbalife Nutrition Revenue in Peptide Health Products Business (2018-2023)
11.5.5 Herbalife Nutrition Recent Developments
11.6 USANA Health Sciences, Inc.
11.6.1 USANA Health Sciences, Inc. Company Details
11.6.2 USANA Health Sciences, Inc. Business Overview
11.6.3 USANA Health Sciences, Inc. Peptide Health Products Introduction
11.6.4 USANA Health Sciences, Inc. Revenue in Peptide Health Products Business (2018-2023)
11.6.5 USANA Health Sciences, Inc. Recent Developments
11.7 Perfect (China) Co., Ltd.
11.7.1 Perfect (China) Co., Ltd. Company Details
11.7.2 Perfect (China) Co., Ltd. Business Overview
11.7.3 Perfect (China) Co., Ltd. Peptide Health Products Introduction
11.7.4 Perfect (China) Co., Ltd. Revenue in Peptide Health Products Business (2018-2023)
11.7.5 Perfect (China) Co., Ltd. Recent Developments
11.8 Nestlé SA
11.8.1 Nestlé SA Company Details
11.8.2 Nestlé SA Business Overview
11.8.3 Nestlé SA Peptide Health Products Introduction
11.8.4 Nestlé SA Revenue in Peptide Health Products Business (2018-2023)
11.8.5 Nestlé SA Recent Developments
11.9 H&H Group
11.9.1 H&H Group Company Details
11.9.2 H&H Group Business Overview
11.9.3 H&H Group Peptide Health Products Introduction
11.9.4 H&H Group Revenue in Peptide Health Products Business (2018-2023)
11.9.5 H&H Group Recent Developments
11.10 China New Era Group Corporation
11.10.1 China New Era Group Corporation Company Details
11.10.2 China New Era Group Corporation Business Overview
11.10.3 China New Era Group Corporation Peptide Health Products Introduction
11.10.4 China New Era Group Corporation Revenue in Peptide Health Products Business (2018-2023)
11.10.5 China New Era Group Corporation Recent Developments
11.11 By-health
11.11.1 By-health Company Details
11.11.2 By-health Business Overview
11.11.3 By-health Peptide Health Products Introduction
11.11.4 By-health Revenue in Peptide Health Products Business (2018-2023)
11.11.5 By-health Recent Developments
11.12 Black Mores
11.12.1 Black Mores Company Details
11.12.2 Black Mores Business Overview
11.12.3 Black Mores Peptide Health Products Introduction
11.12.4 Black Mores Revenue in Peptide Health Products Business (2018-2023)
11.12.5 Black Mores Recent Developments
11.13 Glanbia Plc
11.13.1 Glanbia Plc Company Details
11.13.2 Glanbia Plc Business Overview
11.13.3 Glanbia Plc Peptide Health Products Introduction
11.13.4 Glanbia Plc Revenue in Peptide Health Products Business (2018-2023)
11.13.5 Glanbia Plc Recent Developments
11.14 Nature’s
11.14.1 Nature’s Company Details
11.14.2 Nature’s Business Overview
11.14.3 Nature’s Peptide Health Products Introduction
11.14.4 Nature’s Revenue in Peptide Health Products Business (2018-2023)
11.14.5 Nature’s Recent Developments
11.15 Real Nutriceutical
11.15.1 Real Nutriceutical Company Details
11.15.2 Real Nutriceutical Business Overview
11.15.3 Real Nutriceutical Peptide Health Products Introduction
11.15.4 Real Nutriceutical Revenue in Peptide Health Products Business (2018-2023)
11.15.5 Real Nutriceutical Recent Developments
11.16 China Beijing Tong Ren Tang Group
11.16.1 China Beijing Tong Ren Tang Group Company Details
11.16.2 China Beijing Tong Ren Tang Group Business Overview
11.16.3 China Beijing Tong Ren Tang Group Peptide Health Products Introduction
11.16.4 China Beijing Tong Ren Tang Group Revenue in Peptide Health Products Business (2018-2023)
11.16.5 China Beijing Tong Ren Tang Group Recent Developments
11.17 Xiamen Kingdomway
11.17.1 Xiamen Kingdomway Company Details
11.17.2 Xiamen Kingdomway Business Overview
11.17.3 Xiamen Kingdomway Peptide Health Products Introduction
11.17.4 Xiamen Kingdomway Revenue in Peptide Health Products Business (2018-2023)
11.17.5 Xiamen Kingdomway Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peptide Health Products Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Collagen
Table 3. Key Players of Protein Powder
Table 4. Key Players of Ganoderma Peptide
Table 5. Key Players of Others
Table 6. Global Peptide Health Products Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Peptide Health Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Peptide Health Products Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Peptide Health Products Market Share by Region (2018-2023)
Table 10. Global Peptide Health Products Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Peptide Health Products Market Share by Region (2024-2033)
Table 12. Peptide Health Products Market Trends
Table 13. Peptide Health Products Market Drivers
Table 14. Peptide Health Products Market Challenges
Table 15. Peptide Health Products Market Restraints
Table 16. Global Peptide Health Products Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Peptide Health Products Revenue Share by Players (2018-2023)
Table 18. Global Top Peptide Health Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Health Products as of 2022)
Table 19. Global Peptide Health Products Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Peptide Health Products Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Peptide Health Products, Headquarters and Area Served
Table 22. Global Key Players of Peptide Health Products, Product and Application
Table 23. Global Key Players of Peptide Health Products, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Peptide Health Products Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Peptide Health Products Revenue Market Share by Type (2018-2023)
Table 27. Global Peptide Health Products Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Peptide Health Products Revenue Market Share by Type (2024-2033)
Table 29. Global Peptide Health Products Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Peptide Health Products Revenue Share by Application (2018-2023)
Table 31. Global Peptide Health Products Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Peptide Health Products Revenue Share by Application (2024-2033)
Table 33. North America Peptide Health Products Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Peptide Health Products Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Peptide Health Products Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Peptide Health Products Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Peptide Health Products Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Peptide Health Products Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Peptide Health Products Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Peptide Health Products Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Peptide Health Products Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Peptide Health Products Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Peptide Health Products Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Peptide Health Products Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Peptide Health Products Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Peptide Health Products Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Peptide Health Products Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Peptide Health Products Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Peptide Health Products Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Peptide Health Products Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Peptide Health Products Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Peptide Health Products Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Peptide Health Products Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Peptide Health Products Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Peptide Health Products Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Peptide Health Products Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Peptide Health Products Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Peptide Health Products Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Peptide Health Products Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Peptide Health Products Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Peptide Health Products Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Peptide Health Products Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Peptide Health Products Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Peptide Health Products Market Size by Country (2024-2033) & (US$ Million)
Table 65. Amway Company Details
Table 66. Amway Business Overview
Table 67. Amway Peptide Health Products Product
Table 68. Amway Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 69. Amway Recent Developments
Table 70. Suntory Company Details
Table 71. Suntory Business Overview
Table 72. Suntory Peptide Health Products Product
Table 73. Suntory Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 74. Suntory Recent Developments
Table 75. GNC Company Details
Table 76. GNC Business Overview
Table 77. GNC Peptide Health Products Product
Table 78. GNC Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 79. GNC Recent Developments
Table 80. Infinitus Company Details
Table 81. Infinitus Business Overview
Table 82. Infinitus Peptide Health Products Product
Table 83. Infinitus Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 84. Infinitus Recent Developments
Table 85. Herbalife Nutrition Company Details
Table 86. Herbalife Nutrition Business Overview
Table 87. Herbalife Nutrition Peptide Health Products Product
Table 88. Herbalife Nutrition Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 89. Herbalife Nutrition Recent Developments
Table 90. USANA Health Sciences, Inc. Company Details
Table 91. USANA Health Sciences, Inc. Business Overview
Table 92. USANA Health Sciences, Inc. Peptide Health Products Product
Table 93. USANA Health Sciences, Inc. Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 94. USANA Health Sciences, Inc. Recent Developments
Table 95. Perfect (China) Co., Ltd. Company Details
Table 96. Perfect (China) Co., Ltd. Business Overview
Table 97. Perfect (China) Co., Ltd. Peptide Health Products Product
Table 98. Perfect (China) Co., Ltd. Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 99. Perfect (China) Co., Ltd. Recent Developments
Table 100. Nestlé SA Company Details
Table 101. Nestlé SA Business Overview
Table 102. Nestlé SA Peptide Health Products Product
Table 103. Nestlé SA Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 104. Nestlé SA Recent Developments
Table 105. H&H Group Company Details
Table 106. H&H Group Business Overview
Table 107. H&H Group Peptide Health Products Product
Table 108. H&H Group Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 109. H&H Group Recent Developments
Table 110. China New Era Group Corporation Company Details
Table 111. China New Era Group Corporation Business Overview
Table 112. China New Era Group Corporation Peptide Health Products Product
Table 113. China New Era Group Corporation Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 114. China New Era Group Corporation Recent Developments
Table 115. By-health Company Details
Table 116. By-health Business Overview
Table 117. By-health Peptide Health Products Product
Table 118. By-health Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 119. By-health Recent Developments
Table 120. Black Mores Company Details
Table 121. Black Mores Business Overview
Table 122. Black Mores Peptide Health Products Product
Table 123. Black Mores Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 124. Black Mores Recent Developments
Table 125. Glanbia Plc Company Details
Table 126. Glanbia Plc Business Overview
Table 127. Glanbia Plc Peptide Health Products Product
Table 128. Glanbia Plc Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 129. Glanbia Plc Recent Developments
Table 130. Nature’s Company Details
Table 131. Nature’s Business Overview
Table 132. Nature’s Peptide Health Products Product
Table 133. Nature’s Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 134. Nature’s Recent Developments
Table 135. Real Nutriceutical Company Details
Table 136. Real Nutriceutical Business Overview
Table 137. Real Nutriceutical Peptide Health Products Product
Table 138. Real Nutriceutical Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 139. Real Nutriceutical Recent Developments
Table 140. China Beijing Tong Ren Tang Group Company Details
Table 141. China Beijing Tong Ren Tang Group Business Overview
Table 142. China Beijing Tong Ren Tang Group Peptide Health Products Product
Table 143. China Beijing Tong Ren Tang Group Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 144. China Beijing Tong Ren Tang Group Recent Developments
Table 145. Xiamen Kingdomway Company Details
Table 146. Xiamen Kingdomway Business Overview
Table 147. Xiamen Kingdomway Peptide Health Products Product
Table 148. Xiamen Kingdomway Revenue in Peptide Health Products Business (2018-2023) & (US$ Million)
Table 149. Xiamen Kingdomway Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide Health Products Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Peptide Health Products Market Share by Type: 2022 VS 2033
Figure 3. Collagen Features
Figure 4. Protein Powder Features
Figure 5. Ganoderma Peptide Features
Figure 6. Others Features
Figure 7. Global Peptide Health Products Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Peptide Health Products Market Share by Application: 2022 VS 2033
Figure 9. Tablet Case Studies
Figure 10. Capsule Case Studies
Figure 11. Oral Liquid Case Studies
Figure 12. Others Case Studies
Figure 13. Peptide Health Products Report Years Considered
Figure 14. Global Peptide Health Products Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Peptide Health Products Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Peptide Health Products Market Share by Region: 2022 VS 2033
Figure 17. Global Peptide Health Products Market Share by Players in 2022
Figure 18. Global Top Peptide Health Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Health Products as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Peptide Health Products Revenue in 2022
Figure 20. North America Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Peptide Health Products Market Share by Type (2018-2033)
Figure 22. North America Peptide Health Products Market Share by Application (2018-2033)
Figure 23. North America Peptide Health Products Market Share by Country (2018-2033)
Figure 24. United States Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Peptide Health Products Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe Peptide Health Products Market Share by Type (2018-2033)
Figure 28. Europe Peptide Health Products Market Share by Application (2018-2033)
Figure 29. Europe Peptide Health Products Market Share by Country (2018-2033)
Figure 30. Germany Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China Peptide Health Products Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China Peptide Health Products Market Share by Type (2018-2033)
Figure 38. China Peptide Health Products Market Share by Application (2018-2033)
Figure 39. Asia Peptide Health Products Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia Peptide Health Products Market Share by Type (2018-2033)
Figure 41. Asia Peptide Health Products Market Share by Application (2018-2033)
Figure 42. Asia Peptide Health Products Market Share by Region (2018-2033)
Figure 43. Japan Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Peptide Health Products Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Peptide Health Products Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America Peptide Health Products Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America Peptide Health Products Market Share by Country (2018-2033)
Figure 53. Brazil Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries Peptide Health Products Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Amway Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 60. Suntory Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 61. GNC Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 62. Infinitus Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 63. Herbalife Nutrition Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 64. USANA Health Sciences, Inc. Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 65. Perfect (China) Co., Ltd. Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 66. Nestlé SA Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 67. H&H Group Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 68. China New Era Group Corporation Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 69. By-health Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 70. Black Mores Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 71. Glanbia Plc Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 72. Nature’s Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 73. Real Nutriceutical Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 74. China Beijing Tong Ren Tang Group Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 75. Xiamen Kingdomway Revenue Growth Rate in Peptide Health Products Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed